Title: Introduction to Human CD183/CXCR3 HEK293T Stable Cell Line: A Valuable Tool for Flow Cytometry and Therapeutic Targeting
The Human CD183/CXCR3 HEK293T Stable Cell Line is a valuable scientific tool that has been developed for studying the structure, activity, and potential therapeutic applications of the human chemokine receptor CXCR3. This stable cell line is derived from the HEK293T cell line, which is a commonly used human embryonic kidney cell line in biomedical research. In this article, we will provide a comprehensive overview of the Human CD183/CXCR3 HEK293T Stable Cell Line, highlighting its structure, activity, and potential applications in flow cytometry and as a therapeutic target.
Structure of Human CD183/CXCR3 HEK293T Stable Cell Line
The Human CD183/CXCR3 HEK293T Stable Cell Line is a genetically engineered cell line that expresses the human chemokine receptor CXCR3 stably. CXCR3 is a G protein-coupled receptor that is predominantly expressed on immune cells, including T cells, B cells, and natural killer cells. This receptor is known to play a critical role in immune responses, including inflammation, immune cell trafficking, and host defense against pathogens.
The Human CD183/CXCR3 HEK293T Stable Cell Line is generated by transfecting the HEK293T cells with a plasmid containing the CXCR3 gene and a selectable marker gene. The transfected cells are then selected and maintained in a culture medium containing a selective antibiotic to ensure the stable expression of CXCR3. This stable cell line can be maintained in culture for extended periods, making it a valuable tool for long-term studies.
Activity of Human CD183/CXCR3 HEK293T Stable Cell Line
The Human CD183/CXCR3 HEK293T Stable Cell Line is a functional cell line that expresses CXCR3 on its surface. This stable cell line can be used to study the binding and signaling properties of CXCR3 in response to its natural ligands, CXCL9, CXCL10, and CXCL11. These chemokines are known to play a crucial role in regulating immune cell migration and activation.
The activity of CXCR3 can be assessed using various techniques, including flow cytometry, calcium mobilization assays, and chemotaxis assays. Flow cytometry is a powerful technique that can be used to quantify the expression of CXCR3 on the surface of the Human CD183/CXCR3 HEK293T Stable Cell Line and to assess its binding to fluorescently labeled chemokines. Calcium mobilization assays can measure the activation of CXCR3 signaling pathways, while chemotaxis assays can evaluate the ability of CXCR3 to induce cell migration.
Applications of Human CD183/CXCR3 HEK293T Stable Cell Line
The Human CD183/CXCR3 HEK293T Stable Cell Line has numerous applications in both basic and translational research. As mentioned earlier, this stable cell line can be used to study the structure and activity of CXCR3, providing insights into its role in immune responses. Additionally, this cell line can serve as a valuable tool for drug discovery and development, as CXCR3 is considered a potential therapeutic target for various diseases, including cancer, autoimmune disorders, and inflammatory diseases.
In conclusion, the Human CD183/CXCR3 HEK293T Stable Cell Line is a valuable scientific tool that can be used to study the structure, activity, and potential therapeutic applications of CXCR3. Its stable expression of CXCR3 and functional properties make it an ideal cell line for flow cytometry and as a therapeutic target. Further research using this stable cell line is likely to provide a better understanding of the role of CXCR3 in health and disease, leading to the development of novel therapeutic strategies.
There are no reviews yet.